Daily Posts Archive

Here are 20 Cabot’s top tips that you can use to become a better investor and stay on track when trying to reach your investment goals.

Fourteen months ago today, my column here was about the similarities between riding out a hurricane and investing in choppy markets. That time, the storm was named Irene, and New York City (where I live) escaped most of the damage. Today, a new storm named Sandy is just beginning to...

Whether you’ve got an appetite for small-cap stocks or value stocks, Cabot has a publication that will fit your needs.

Here at Cabot we try to find out which way markets are trending and manage our portfolios accordingly.

“Molson Coors Brewing Company (TAP) has completed its $3.4-billion purchase of StarBev, which owns nine breweries in Central and Eastern Europe. In the three months ended June 30, 2012, this acquisition contributed $19.7 million to Molson Coors’s pre-tax earnings. That helped push up the company’s overall earnings by...

In today’s Stock Market Crash Course, we hear from Institutional Investor’s John Gray, Momentum Strategies Report’s Clif Droke, Christopher Mistal of Stock Trader’s Almanac and Richard Rhodes of The Rhodes Report. The consensus is to beware of further downside in the near-term, although there are still some signs of hope...

Two companies that fit Warren Buffett’s and Ben Graham’s stock selection criteria are American Express and UnitedHealth Group.

Cabot Market Letter Editor Mike Cintolo shares his favorite investment maxims and advises how to implement them.

Have you ever wondered how to find great biotech stocks in a sea of hopeful but high-risk medical small caps? Well, for my latest Dick Davis Digest contributor interview, I interviewed John McCamant, the editor of a top-performing investment newsletter that’s all about finding the best biotech stocks. So if...

There are some very convincing signs that Chinese stocks are about to turn around in a massive way.